Healthcare & Life Sciences

Medincell

Medincell is a Healthcare & Life Sciences startup based in France, most recent round Series C+, 1 tracked investor.

series-c-plus
series-c-plus
Stage
1
Investors

About Medincell

Based in France, Medincell is a startup. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.

Medincell develops long-acting injectable drug-delivery technologies (BEPO®) and therapeutic products, partnering with pharma companies to commercialize treatments such as UZEDY (risperidone) and investigational olanzapine and celecoxib formulations.

Explore Medincell's full profile on Brouky

Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.

Other Startups in France